Hu7691 free base is an orally active, selective Akt inhibitor with IC 50 s of 4.0 nM, 97.5 nM, 28 nM for Akt1 , Akt2 and Akt3 , respectively. Hu7691 free base inhibits tumor growth and enables decrease of cutaneous toxicity in mice.
Products | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > TGF-beta/Smad | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Akt | Products > Signaling Pathways > PKA | Products > Signaling Pathways > PKC | Products > Signaling Pathways > ROCK | Products > Signaling Pathways > Ribosomal S6 Kinase (RSK) | Products > Signaling Pathways > SGK
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.